World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
33705
World Ranking
9669
National Ranking
296

Myriam Labopin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Myriam Labopin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 909 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Myriam Labopin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Myriam Labopin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Myriam Labopin is affiliated with Université Paris Cité in France and has an extensive research portfolio in the field of medicine, with a significant focus on hematology. Their work encompasses a broad range of topics closely related to hematopoietic stem cell transplantation and leukemia research.

The main fields of study covered in Myriam Labopin's research include:

  • Medicine

Within this broader medical field, they have contributed significantly to several subfields:

  • Hematology
  • Public Health, Environmental and Occupational Health
  • Oncology
  • Immunology
  • Genetics

The primary topics of Myriam Labopin's research activity emphasize stem cell transplantation and leukemia, including:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Polyomavirus and Related Diseases
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction

Key recent papers authored by or associated with Myriam Labopin exemplify their research interests and include:

  • Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients, 2020, Bone Marrow Transplantation
  • COVID-19 outcomes in patients with hematologic disease, 2020, Bone Marrow Transplantation
  • Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP), 2020, Frontiers in Immunology
  • Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, 2020, Haematologica
  • Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation, 2021, JACC CardioOncology

Frequent co-authors in Myriam Labopin's network include:

  • Mohamad Mohty
  • Arnon Nagler
  • Fabio Ciceri
  • Didier Blaise
  • Éolia Brissot

The scientist has published extensively in specific venues known for hematology and transplantation research. These venues include:

  • Bone Marrow Transplantation
  • Blood
  • Transplantation and Cellular Therapy
  • American Journal of Hematology
  • Biology of Blood and Marrow Transplantation

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

    Aurelien Latouche;Aurelien Latouche;Arthur Allignol;Jan Beyersmann;Myriam Labopin

  • Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

    Dominique Farge;Myriam Labopin;Alan Tyndall;Athanasios Fassas

  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

    Eliane Gluckman;Barbara Cappelli;Francoise Bernaudin;Myriam Labopin

  • A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

    Fabio Ciceri;Myriam Labopin;Franco Aversa;Jakob M. Rowe

  • Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

    J A Snowden;R Saccardi;M Allez;S Ardizzone

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

  • Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Rafael F. Duarte;Myriam Labopin;Peter Bader;Grzegorz W. Basak

  • Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

    Christine Bellanné-Chantelot;Isabelle Chaumarel;Myriam Labopin;Florence Bellanger

  • Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

    A Ruggeri;M Labopin;F Ciceri;M Mohty

  • Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study

    Francesco Frassoni;Francesca Gualandi;Marina Podestà;Anna Maria Raiola

  • Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

    Olle Ringdén;Myriam Labopin;Gerhard Ehninger;Dietger Niederwieser

  • Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.

    Mohamad Mohty;Myriam Labopin;Liisa Volin;Alois Gratwohl

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Dietger Niederwieser

  • CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

    Martin Schmidt-Hieber;Myriam Labopin;Dietrich Beelen;Liisa Volin

  • Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

    V. Runde;T.J.M. de Witte;R. Arnold;A. Gratwohl

  • Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Olle Ringdén;Myriam Labopin;Norbert Claude Gorin;Katarina Le Blanc

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Gérard Socié
Gérard Socié Université Paris Cité
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Christoph Schmid
Christoph Schmid University of Augsburg
Jürgen Finke
Jürgen Finke University of Freiburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up diverse educational options beyond traditional medical school. For registered nurses aiming to advance quickly, adn to np programs online offer a streamlined path from an associate degree in nursing to becoming a nurse practitioner. These flexible programs make it easier for working professionals to upskill without interrupting their careers.

Interested in nutrition and preventative health? Pursuing an online bachelor's in nutrition can be a strategic move, leading to roles in public health, wellness coaching, or clinical dietetics. Likewise, for those seeking leadership in healthcare, top online mha programs that are cahme accredited equip graduates with vital management skills tailored for hospital and health services administration.

Many programs also accommodate non-traditional students. For example, nurses can expand their credentials conveniently with an rn to bsn with no clinicals program, reducing time spent away from work. Exploring these online options can accelerate your pathway into more specialized or advanced healthcare roles.

Best Scientists Citing Myriam Labopin

Trending Scientists

Recently Published Articles